Diabetes patients have a higher risk of coronary artery stent re-narrowing and clot formation than non-diabetics, affecting both Type 1 and Type 2 diabetes patients.
A Swedish study has found that patients with diabetes have a significantly increased risk of their coronary artery stents re-narrowing and developing clots compared to non-diabetic patients. This risk affects both Type 1 and Type 2 diabetes individuals, highlighting a concerning trend in cardiovascular health among diabetic populations. The research analyzed data from Swedish patients who received next-generation drug-eluting stents during balloon angioplasty between 2010 and 2020, totaling 160,000 patients.
